62.

Mandal MK, Gosh S, Bhat HR,Naesens L, Singh UP* (2021) Facile synthesis, antimicrobial and antiviral evaluation of novel substituted phenyl 1,3-thiazolidin-4-one sulphonyl derivatives.  Bioorganic Chemistry, 114,  105153  (Impact factor 5.2)

61.

Singh S, Mandal MK, Masih A, Saha A, Gosh SK, Bhat HR, Singh UP* (2021) 1,3,5-Triazine: A versatile pharmacophore with diverse biological activities. Archiv Der Pharmazie, 354, 2000363. (Impact factor 3.7)

60.

Gogoi P, Shakya A, Gosh SK, Gogoi N, Nardev S, Bhattcharya DR, Singh UP, Bhat HR (2021) In silico study, synthesis and evaluation of antimalarial activity of hybrid dimethoxy pyrazole 1,3,5-triazine derivatives. Journal of Biochemical and Molecular Toxicology,  e22682 (Impact factor: 3.6) 

59.

Mandal MK, Gosh S, Bhat HR,Naesens L, Singh UP* (2020) Synthesis and biological evaluation of substituted phenyl azetidine-2-one sulphonyl derivatives as potential antimicrobial and antiviral agents, Bioorganic Chemistry, 104, 104320. (Impact factor 5.2)

58.

Kashyap A, Choudhury A, Saha A, Adhikari N, Ghosh SK, Shakya A, Patgiri S, Bhattacharya D, Singh UP, Bhat HR (2020)  Microwave assisted development of hybrid PABA-1,3,5-triazine derivatives as antimalarial agent against wild and mutant malaria parasites.  Journal of Biochemical and Molecular Toxicology,  35, e22860 (Impact factor 3.6)

57.

Masih A, Singh S, Agnihotri A,  Srivastava JK, Pandey N, Bhat HR, Singh UP* (2020) Discovery of novel 1,3,5-triazine as adenosine A2A receptor antagonist for benefit in Parkinson’s Disease.  Journal of Biochemical and Molecular Toxicology, 35,  e22659 (Accepted, Impact factor 3.6)

56.

Masih A, Singh S, Agnihotri A,  Srivastava JK, Bhat HR, Singh UP* (2020) Discovery of novel pyrazole derivatives as potent anti-inflammatory agent in RAW 264.7 cells via inhibition of NF-ĸB for possible benefit against SARS-CoV-2.  Journal of Biochemical and Molecular Toxicology,  35, e22656 (Impact factor 3.6)

55.

Masih A, Singh S, Agnihotri A, Giri S, Srivastava JK, Pandey N, Bhat HR, Singh UP* (2020)  Design and development of 1,3,5-triazine-thiadiazole hybrids as potent adenosine A2A receptor antagonist for benefit in Parkinson's Disease. Neuroscience letters, 735, 135222. (Impact factor 3.0)

54.

Das A, Shakya A, Ghosh SK, Singh UP, Bhat HR (2020)  A review of phytochemical and pharmacological studies of inula species.  Current Bioactive Compounds, 16, 557-567

53.

Masih A, Srivastava JK, Bhat HR, Singh UP* (2020) Potent antibacterial activity of Dihydydropyrimidine-1,3,5-triazines via inhibition of DNA gyrase and antifungal activity with favourable metabolic profile, Chemical Biology and Drug Design, 96,  861-869.  (IMPACT FACTOR= 2.8).

52.

Bhat HR, Masih A, Shakya A, Ghosh SK, Singh UP* (2020) Design, synthesis, anticancer, antibacterial and antifungal evaluation of 4-aminoquinoline-1,3,5-triazine derivatives.  Journal of Heterocyclic Chemistry, 57, 390-399 (IMPACT FACTOR=2.1)

51.

Adhikari N, Kashyap A, Shakya A, Gosh SK, Bhattacharya DR, Bhat HR, Singh UP. (2020) Microwave assisted synthesis, docking and antimalarial evaluation of hybrid PABA-substituted 1,3,5-triazine derivatives, Journal of Heterocyclic Chemistry,  57, 2389-2399. (IMPACT FACTOR= 2.1)

50.

Kumawat M, Singh UP, Chetia D. (2019) Design and discovery of 3,6-substituted 1,2,4,5-tetraoxanes as new class of Falcipain-2 inhibitors for antimalarial action, Pharmaceutical Chemistry Journal,  53, 822–830. (IMPACT FACTOR= 0.83) 

49.

Sahu S., Ghosh S.K., Gahtori P., Singh U.P., Bhattacharyya D.R., Bhat H.R. (2019) In silico ADMET study, Docking, Synthesis and Antimalarial evaluation of thiazole-triazine derivatives as Pf-DHFR inhibitor. Pharmacological Reports, 71, 762-767. (IMPACT FACTOR= 3.0)

48.

Singh UP,  Bhat HR. (2019)  Discovery of novel pyrazole based dual inhibitor of HIV and HCV together with attenuation of oxidative stress. HIV Medicine, 20, 98. (IMPACT FACTOR= 3.1)

47.

Singh UP, Bhat HR. (2018) Discovery of 1,3,5-triazine-thiazoles (DDTR-502) as potent A2A antagonist/MAO-B inhibitor for the treatment of Parkinson’s disease. Parkinsonism & Related Disorders. 46(2), e39-e40. (IMPACT FACTOR= 4.8)

46.

Singh UP, Srivastava JK, Verma A, Bhat HR. (2018) Targeting immune and non-immuno synovitis by 1,3,5-triazine-thiazole via dual inhibition of NF-κB and EGFR-TKs for possible benefit in rheumatoid arthritis.  Annals of the Rheumatic Diseases 76 (2): 176 (IMPACT FACTOR= 19.10)

45.

Kashyap A, Adhikari N, Das A, Shakya A, Ghosh SK, Singh UP, Bhat HR. (2018) Review on Synthetic Chemistry and Antibacterial Importance of Thiazole Derivatives. Curr Drug Discov Technol. 15 (3) 214-228.

44.

Srivastava JK,  Pillai G, Bhat H.R, Verma A, Singh UP. (2017) Design and discovery of novel monastrol-1,3,5-triazines as potent antibreast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase. Scientific Reports, 7, 5851. (IMPACT FACTOR= 5.25)

43.

Singh UP,  Shrivastava J. K.,  Verma A.,  Bhat H.R. (2017) Discovery of 1,3,5-triazine-monastrol based novel EGFR-tyrosine kinase inhibitor against human lung carcinoma. Annals of Oncology (2017) 28 (suppl_2): 10. (IMPACT FACTOR=32.97)

42.

Verma A, Kumar V,  Singh UP. (2017)  Development of novel 1,2,4-triazole-thiol derivatives as dual PI3K/mTOR inhibitor against the non-small cell lung cancer (NSCLC).  Annals of Oncology 28 (suppl_2):  12. (IMPACT FACTOR=9.62)

41.

Singh UP, Bhat HR. (2017) Discovery of 1,3,5-Triazine Based Novel EGFR-Tyrosine Kinase Inhibitor against Human Lung Carcinoma. Journal of Thoracic Oncology, 12, S1494-95. (IMPACT FACTOR=15.04)

40.

Singh UP, Shrivastav JK, Bhat HR. (2016) Discovery of novel 1,3,5-triazine-thiourea based dual PI3K/ mTOR inhibitor against Non-small cell lung cancer (NSCLC).  Annals of Oncology, 27, IX50. (IMPACT FACTOR=32.97)

39.

Kumawat MK, Singh UP, Singh B, Prakash A, Chetia D. (2016) Synthesis and antimalarial activity evaluation of 3-(3-(7-chloroquinolin-4-ylamino) propyl)-1,3-thiazinan-4-one derivatives. Arabian Journal of Chemistry, 9, S643—S647. (IF = 5.16)

38.

Bhat HR, Singh UP, Subhashchandra YP, Kumar V, Gahtori P, Das A, Chetia D, Prakash A, Mahanta J. (2016) Synthesis and antimalarial activity evaluation of some analogues of 7-chloro-N- [3-(4,6-diamino-1,3,5-triazin-2-ylamino)propyl]uinolone-4-amine derivatives. Arabian Journal of Chemistry, 9, S625-631. (IF = 5.16)

37.

Shrivastav JK, Awatade NT, Kimit A, Medes K, Ramos M, Amaral MD, Singh UP* (2015) Pharmacological evaluation of hybrid thiazolidin-4-one-1,3,5-triazines for NF-κB, biofilm and CFTR activity. RSC Advances, 2015,5, 88710-88718. (IMPACT FACTOR=3.84)

36.

Pathak P, Thakur A, Bhat HR, Singh UP (2015) Hybrid 4-Aminoquinoline-1,3,5-triazine Derivatives: Design, Synthesis, Characterization, and Antibacterial Evaluation, Journal of Heterocyclic Chemistry, 52, 1108-1113 ((IF = 2.1)

35.

Singh UP, Srivastava JK, Bhat HR (2015) Structure-based optimization and discovery of novel 1,3,5-triazine derivatives as bacterial translation inhibitor with favourable metabolic fate. Antimicrobial Resistance and Infection Control, 4(Suppl 1):I2, (IF = 4.8)

34.

Srivastava JK, Dubey P, Bhat HR, Kumawat MK, Singh UP* (2015) Discovery of novel 1,3,5-triazine-thiazolidine-2,4-diones as dipeptidyl peptidase-4 (DPP-4) inhibitor targeting S1 pocket for the treatment of type 2 diabetes along with antibacterial activity, RSC Advances, 5, 14095-14102(IMPACT FACTOR= 3.84)

33.

Bhat HR, Singh UP, Gahtori P, Ghosh SK, Gogoi K, Prakash A, Singh RK (2015)  Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives, Experimental Parasitology,  157:59-67  (IF = 2.03)

32.

Bhat HR, Singh UP, Gahtori P, Ghosh SK, Gogoi K, Prakash A, Singh RK (2015) Synthesis, docking,  in vitro and in vivo antimalarial activity of hybrid 4-aminoquinoline-1,3,5-triazine derivatives against wild and mutant malaria parasites, Chemical Biology & Drug Design,86, 265-271 (IF = 2.8)

31.

Singh UP*, Bhat HR (2014) Substituted 1,3,5-triazine derivatives as adenosine A2A receptor antagonists: Synthesis, structure-activity relationships and molecular modelling studies, Movement Disorder, 29, S62. (IF = 10.33)

30.

Singh UP*, Bhat HR (2014) Design and Discovery of Pyrazole and Pyrimidine as Novel Class of Potent Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs). AIDS Research and Human Retroviruses, 30, A206. (IF = 2.2)

29.

Singh B, Bhat HR, Kumawat MK, Singh UP* (2014) Structure-guided discovery of 1,3,5-triazine-pyrazole conjugates as antibacterial and antibiofilm activity against pathogen causing human diseases with favourable metabolic fate. Bioorganic & Medicinal Chemistry Letters, 24, 3321-5. (IF = 2.84)

28.

Bhat HR, Singh UP, Gahtori P, Ghosh SK, Gogoi K, Prakash A, Singh RK. (2014). 4-Aminoquinoline-1,3,5-triazine: Design, synthesis, in vitro antimalarial activity and docking studies. ChemInform Abstract, 45, DOI: 10.1002/chin.201404181

27.

Singh UP*, Bhat HR, Kumawat MK, Singh RK. (2013) Utilisation of Home Laundry Effluent (HLE) as a catalyst for the expeditious one-pot aqueous phase synthesis of highly functionalised 4-thiazolidinones, SpringerPlus, 2, 466.

26.

Singh UP*, Bhat HR, Verma A, Kumawat MK, Singh RK (2013) Phenylhydrazone bearing pyrazole and pyrimidine scaffolds: Design and discovery of novel class of Non-nucleoside Reverse Transcriptase Inhibitor (NNRTIs) against HIV-1 and their antibacterial properties. RSC Advances, 3, 17335-17348.(IF = 3.84)

25.

Bhat HR, Singh UP, Gahtori P, Ghosh SK, GogoiKabita, Prakash A, Singh RK. (2013). 4-Aminoquinoline-1,3,5-triazine:Design, synthesis, in vitro antimalarial activity and docking studies. New Journal of Chemistry, 37, 2654-2662.(IF = 3. 5)

• Selected for cover page of New Journal of Chemistry for September 2013 Issue
• Selected as HOT ARTICLE for the month of July, 2013 by Editorial Board of New Journal of Chemistry

24.

Bhat HR, Pandey P, Ghosh SK, Singh UP (2013) Development of 4-aminoquinoline-1,3,5-triazine conjugates as potent antibacterial agent through facile synthetic route. Med. Chem. Res. 22, 5056-5065. (IF = 1.6)

23.

Singh UP*, Bhat HR, Gahtori P, Singh RK (2013) Hybrid thiazole-1,3,5-triazines target cytosolic Leucyl-tRNAsynthetase for antifungal action revealed by molecular docking studies. In Silico Pharmacology, 1, 3.

• Ranked as top 10 most viewed article since its publication

22.

Kumar S, Bhat HR, Kumawat MK, Singh UP* (2013) Design and one-pot synthesis of hybrid thiazolidin-4-one-1,3,5-triazines as potent antibacterial agent against human disease causing pathogens. New Journal of Chemistry, 37, 581-584. (IF = 3.5)

21.

Bhat HR, Singh UP, Gahtori P, Ghosh SK, Gogoi K., Prakash A, Singh RK. (2013). Design, synthesis, in vitro antimalarial activity and docking studies of novel bifunctional hybrids derived from 4-aminoquinoline and 1,3,5-triazine against wild and mutant malaria parasites. RSC Advances, 3, 2942-2952. (IF = 3.84)

20.

Singh UP*, Bhat HR, Singh RK (2012) Ceric ammonium nitrate catalysed expeditious one-pot synthesis of 1,3-thiazine as IspE kinase inhibitor of Gram-negative bacteria using polyethylene glycol (PEG-400) as an efficient recyclable reaction medium. Comptes Rendus Chimie(International Journal of Chemistry), 16, 462-468. (IF = 3.11)

19.

Bhat HR, Gupta SK, Singh UP. (2012) Discovery of potent, novel antibacterial hybrid conjugates from 4-aminoquinoline and 1,3,5-triazine: Design, synthesis and antibacterial evaluation. RSCAdvances, 2, 12690-12695. (IF = 3.84)

18.

Singh UP*. (2012) PEG-400 Synlett, 23, 2721-2122.(IF = 2.46)

17.

Singh UP*, Pathak M, Dubey V. Bhat HR, Singh RK (2012) Synthesis, antibacterial activity and molecular docking studies on Hybrid 1,3-thiazine-1,3,5-triazine Derivatives: Novel Bacterial Translation Inhibitors. Chemical Biology and Drug Design, 80, 572-583. (IF = 2.8)

16.

Dubey V, Pathak M, Bhat HR, Singh UP* (2012) Design, synthesis, antibacterial activity and molecular properties prediction of hybrid 1,3,4-thiadiazole-1,3,5-triazine derivatives tethered via –S- bridge. Chemical Biology and Drug Design. 80, 598-604.(IF = 2.8)

15.

Gahtori P, Ghosh SK, Pratap P, Prakash A, Gogoi K, Singh UP*. (2012) Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: A novel and potential antifolate lead for Pf-DHFR-TS inhibition. Experimental Parasitology, 130, 292-299.(IF = 2.03)

• Featured in TOP THREE Hot Articles for the March 2012 in Malarianexus.
• Cited as TOP THREE most downloaded paper from Experimental Parasitology in last 90 days according to SciverseSciencedirect Scopus (Jan-Mar 2012).

14.

Bhat HR, Gosh SK, Prakash A, Gogoi K, Singh UP*. (2012) In vitro antimalarial activity and docking studies on hybrid 4-aminoquinoline-1,3,5-triazines. Letters in Applied Microbiology, 54, 483-486. (IF = 2.8)

13.

Singh UP*, Bhat HR, Gahtori P. (2012) Antifungal activity, SAR and physicochemical correlation of some hybrid thiazole-1,3,5-triazine derivatives, Journal de Mycologie Médicale, 22, 134-144.(IF = 2.3)

• Featured in top three among the 25 hottest articles from Journal de MycologieMédicale from Jan-Dec 2012.
• Featured among the 25 hottest articles from Journal de MycologieMédicale from April-September 2013

12.

Yadav PS, Kumar V, Singh UP, Bhat H, Mazumder B. (2013) Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and d-mannitol. Saudi Pharmaceutical Journal, 21, 77-84.(IF = 4)

11.

Gahtori P, Ghosh SK, Singh B, Singh UP, Bhat HR, Archana U. (2012) Synthesis, SAR and antibacterial activity of hybrid chloro, dichloro-phenylthiazolyl-s-triazines. Saudi Pharmaceutical Journal, 20, 35-43.(IF = 4)

10.

Ghosh SK, Saha A, Hazarika B, Singh UP*, Bhat HR, Gahtori P. (2012) Design, Facile Synthesis, Antibacterial Activity and Structure-Activity Relationship of Novel Di- And Tri-Substituted 1,3,5- Triazines, Letters in Drug Design and Discovery, 9, 329-335.(IF = 1.15)

9.

Singh UP*, Singh RK. (2011) Molecular Docking Analysis of Novel Non-Nucleoside Reverse Transcriptase Inhibitor in Development: Implication for Rational Drug Design. Retrovirology, 8(Suppl 2):P82.(IF = 4.6)

8.

Ahmed D, Singh UP*. (2011) Letter to the Editor regarding Saraogi et al., Biomedicine & Ageing Pathology. 1, 196.

7.

Singh UP*, Singh RK, Bhat HR, Subhashchandra YP, Kumar V, Kumawat MK, Gahtori P. (2011) Synthesis and antibacterial evaluation of series of novel tri substituted-s-triazine derivatives. Medicinal Chemistry Research, 20, 1603-1610.(IF = 1.6)

6.

Junejo JA, Ghosh SK, Saikh M, Gahtori P, Singh UP*. (2011) Facile synthesis, antibacterial activity and molecular properties prediction of some new 1,3-dihydroimidazol-2-thione derivatives. Letters in Drug Design and Discovery, 8, 763-768.(IF = 1.15)

5.

Singh UP*, Gahtori P, Singh RK. (2011) In-vitro Antifungal Activity of Some 1,3,5-triazine Derivatives. Nature Precedings, doi: 10101/npre.2011.5751.1

4.

Singh UP*, Bhat HR, Yadav PS, Kumar V, Bhattacharya A, Chetia D, Das A. (2010) Synthesis and antibacterial evaluation some novel 2,4,6-trisubsituted-1,3,5-triazine derivatives. Latin American Journal of Pharmacy, 29; 607-611. (IF 0.24)

3.

Singh UP*, Bhat HR, Subhashchandra YP, Kumar V, Kumawat MK, Gahtori P. (2010) Synthesis and antibacterial evaluation of series of novel tri substituted-s-triazine derivatives. Medicinal Chemistry Research, 19; S132.(IF = 1.6)

2.

Bhat HR, Singh UP, Subhashchandra YP, Kumar V, Gahtori P, Das A, Chetia D, Prakash A, Mahanta J. (2010) Synthesis and Antimalarial activity evaluation of some analogues of 7-chloro-N-[3-(4,6-diamino-1,3,5-triazin-2-ylamino)propyl]-quinolone-4-amine derivatives. Medicinal Chemistry Research, 19; S68.(IF = 1.6)

1.

Kumawat MK, Chetia D, Prakash A, Singh UP. (2010) Synthesis and antimalarial activity evaluation of 3-(3-(7-chloroquinolin-4-ylamino) propyl)-1,3-thiazinan-4-one derivatives. Medicinal Chemistry Research, 19; S89.(IF = 1.6)

1.

Singh UP, Shrivastava JK, Bhat HR.  Discovery of Novel diaryltriazines (DATAs) as NNRTIs via extension into the entrance channel of HIV-1 reverse transcriptase. Asia Pacific AIDS & Co-infections Conference, Hong Kong, China May 16-19, 2016.

2.

Singh UP, Shrivastava JK, Bhat HR.  Discovery of novel monastrol-1,3,5-triazine conjugates targeting Rad6B as antiproliferative agent. International Chemical Congress of Pacific Basin Societies, Honolulu, Hawaii, USA. December 15 – 20, 2015.

3.

Singh UP, Shrivastava JK, Bhat HR. Discovery of Novel Imeglimin derivatives as DPP-4 inhibitors targeting S1 pocket for the treatment of type 2 diabetes along with antibacterial activity.  International Diabetes Federation World Diabetes Conference, Vancouver, Canada, 30 November – 4 December 2015.

4.

Bhat HR, Singh UP, Ghosh SK. Synthesis and antibacterial and antifungal  evaluation of Novel 4-Aminoquinoline semicarbazide conjugates. National Conferences on Emerging Trends in Pharmaceutical & Biotechnological Research, Anand college of Pharmacy Agra, India, November 06-07, 2015.

5.

Singh UP, Srivastava JK, Bhat HR. Discovery of Novel Diaryltriazines (DATAs) as Non-nucleoside Reverse Transcriptase inhibitors via Extension into the Entrance channel of HIV-1 Reverse Transcriptase. international conferences on 15th European Aids Conference, Barcelona, Spain 21-24 October 2015.

6.

Verma A, Bhat HR, Singh UP. Design and Discovery of potent Hybrid 1,3,5-triazines-1,3-Thiazine Analogs Clubbed via Amide Bridge: A Novel Lead for next generation NNRTI. International conferences on 15th European Aids Conference, Barcelona, Spain 21-24 October 2015.

7.

Singh UP, Shrivastava JK. Bhat HR. Structure-based Optimization and Discovery of Novel 1,3,5-triazine Derivatives as Bacterial Translation Inhibitor with favourable metabolic fate. International conference on Prevention and Infection Control, Geneva, Switzerland, 16-19 June, 2015.

8.

Singh UP, Bhat HR. Design and discovery of Phenyl hydrazone bearing pyrazole and pyrimidine scaffolds as novel class of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs). HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science, Cape Town, South Africa, October 28-31, 2014

9.

Singh UP, Singh RK. Discovery of novel 1,3,5-triazine-thiazolidine-2,5-diones as p50 NF-κB inhibitor involved in cystic fibrosis along with potent antibacterial and biofilm inhibitory activity. 8th European CF Young Investigator Meeting Paris, France, February 19th to 21st 2014.

10.

Singh UP. Discovery of Novel class of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Agents, 2^nd Innovative Approaches for Identification of Antiviral Agents Summer School, Pula, Italy, September 28th – October 3rd 2014.

11.

Singh UP, Bhat HR. Structure based optimization anddiscovery of potent 1,3,5-triazine-pyrazoleconjugates as bacterial translation inhibitor. 8^thWorld Congress of the World Society for Paediatric Infectious Diseases (WSPID) to take place in Cape Town, South Africa, November 19-22, 2013.

12.

Singh UP, Bhat HR, Pathak MK, Dubey V, Yadav PK, Singh RK. Molecular Docking Studies of Hybrid 1,3-thiazine-s-1,3,5-triazene Derivatives Against r-RNA: Novel Bacterial Translation Inhibitors. International Conference on MedChem 2011 at IICT/NIPER Hyderabad. India, Feb 25 and 26, 2011. (Co-organized with Royal Society of Chemistry, UK)

13.

Bhat HR, Singh UP, Yadav PK, Ghosh SK, Prakash A, Mahanta J. Synthesis and Molecular Docking Studies of Hybrid 4-aminoquinoline s-triazines. International Conference on MedChem 2011 at IICT/NIPER Hyderabad. India, Feb 25 and 26, 2011.

14.

Singh UP, Bhat HR, Parveen A, Singh RK, Ranjan P, Ratna D, Ajit K, Singh RK. Synthesis of Aromatic Hydrazones as Potential Anti-HIV Candidate. National Seminar on Health and Environment: Issues and Challenges at Faculty of Health Medical Sciences, Alternative and Indigenous Systems of Medicine, Sam Higginbottom Institute of Agriculture Technology and Sciences. Allahabad, India. May 06-07, 2010

15.

Singh UP, Tripathi A, Kumar D, Prakash R, Singh DP, Bhat HR, Singh RK. Pharmacophore- Based Design and Synthesis of Novel Substituted Thiazoles Containing Pyrazolinone, Pyrazole and Pyrimidinone Moieties as Promising Anti-HIV Candidate. National Seminar on Health and Environment: Issues and Challenges at Faculty of Health Medical Sciences, Alternative and Indigenous Systems of Medicine, Sam Higginbottom Institute of Agriculture Technology and sciences. Allahabad, India. May 06-07, 2010

16.

Singh UP, Pathak MK, Dubey V, Singh RK. Anti-HIV Drugs: Where We Stand Now. National Seminar on Health and Environment: Issues and Challenges at Faculty of Health Medical Sciences, Alternative and Indigenous Systems of Medicine, Sam Higginbottom Institute of Agriculture Technology and sciences. Allahabad, India. May 06-07, 2010.

17.

Kaithwas G, Singh UP, Yadav PS, Kumar V, Bhat HR, Ahmed D. Diagnosis of Filarial Parasites. 61st Indian Science Congress, Trivandrum, 3-7 January 2010.

18.

Ahmed D, Singh UP, Kumar V, Yadav PS, Bhat HR. Effect of Rosiglitazone, Atorvastatin and Glimipride on Glycemic control and Lipid Profile on STZ induced NIDDM rats. (Oral Presentation, 61st Indian Science Congress, Trivandrum, 3-7 January 2010

19.

Kumar V, Yadav PS, Singh UP, Bhat HR, Ahmed D. Review: Method for Evaluation of in-vivo and in-vivo Antioxidant Activity. 61st Indian Science Congress, Trivandrum, 3-7 January 2010

20.

Yadav PS, Kumar V, Singh UP, Bhat HR, Ahmed D, Mazumdar B. Pysico-chemical characterisation and in-vitro dissolution studies of solid dispersion of Ketoprofen with PVK 30 and D-Mannitol. (61st Indian Science Congress, Trivandrum, India 3-7 January 2010.

21.

Kumar V, Yadav PS, Singh UP, Bhat HR, Ahmed D. Natural Product as Anticancer. “International Conference on Herbal Drugs” JSS College of Pharmacy, Ooty, Tamilnadu; 4-5 Dec 2009.

22.

Shanghai N, Gupta A, Singh UP. Antibiotic Resistance- A Sensitive Issue. "46 Indian Hospital Pharmacists Association National Convention" held at Scientific Convention Centre, K.G.M.U., Lucknow on 24-25 October 2009.

23.

Singh UP, Yadav PS, Bhattacharya A, Chetia D, Das A. Synthesis and Antibacterial Evaluation of Some Novel 2,4,6-trichloro-1,3,5-triazine derivatives.” II Louis Pasture Memorial National Symposium on Antimicrobial Resistance and Drug Discovery, Dr. N.G.P. Arts and Science College, Coimbatore; 9th-10th September 2009. (Best Poster Presentation).

24.

Singh UP, Bhat HR, Kumar V, Yadav PS, Chetia D, Ghosh SK. Herpes simplex virus - Antiviral drug resistance” National Conference on Emerging Trends in Pharmaceutical Sciences, Jammu University, Shrinagar, India Jammu, 8-9 March 2009.

25.

Singh UP,  Yadav  PS,  Bhattacharya  A,  Chetia  D,  Das  A. Synthesis  of  Some 1,3,5-Triazine Derrivatives.” Emerging Trends in Novel Drug Delivery Systems, at H.R. Institute of Pharmacy, Ghaziabad, India; 27th-28th March 2009

26.

Singh UP, Yadav PS, Kumar V, Bhattacharya A, Chetia D, Das A. Synthesis and Antibacterial Evaluation of Some Novel 2,4,6-tri chloro-1,3,5-triazine derivatives.” Antimicrobial Resistance: From Emerging Threat to Realty, at Allahabad Agricultural Institute-Deemed University, India, 23rd-25th March 2009

Professional Membership

Research Collaborators

Fellowships/ Awards/ Honours

2021

Early Career Chemist Award (American Chemical Society, USA), 2021 International Congress of Pacific Basin Societies, December 15-20, 2021, Honolulu, Hawaii, (Sponsored by: American Chemical Society, Canadian Society for Chemistry, Chemical Society of Japan, New Zealand Institute of Chemistry, Royal Australian Chemical Institute, Korean Chemical Society, Chinese Chemical Society) USA.

2020

International Antiviral Research Society (IARS) Travel Grant to attend The 33rd International Conference on Antiviral Research (ICAR), Seattle, USA from 2020-03-30 till 2020-04-03.

2019

WCN Travel Grant to attend  24th World Congress of Neurology 2019 in Dubai, UAE, Oct 27-31, 2019

2019

Innovation Academy Award Presentation at 5^th International Conference on Prevention & Infection Control - (ICPIC 2019) Geneva, Switzerland via ICPIC Travel Grant  from 10 to 13 September 2019 in Geneva, Switzerland

2019

Taylor and Francis Travel Grant to attend  6th World Conference on Research Integrity, Hong Kong, 2-5 June 2019.

2019

AOPMC Travel Grant to attend 6th Asian and Oceanian Parkinson's Disease and Movement Disorders Congress (AOPMC), April 12-14, 2019, China

2019

Korean Society of Hematology Travel Grant to attend 2019 KSH International Conference & the 60th Annual Meeting, Seoul, South Korea, March 14 to 16, 2019.

2018

International Association of Parkinsonism and Related Disorders Travel Grant to attend International Association of Parkinsonism and Related Disorders Congress, 19 – 22 August 2018, Lyon, France

2018

International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) Travel Grant to attend International Symposium on Pneumococci and Pneumococcal Diseases Conference, 15-19 April, 2018, Melbourne Australia

2018

Korean Society of Nephrology (KSN) Travel Grant to attend 38th Annual Meeting of the Korean Society of Nephrology in Seoul, South Korea, May 17-20, 2018

2017

International Association of Parkinsonism and Related Disorders Travel Grant,  to attend  XXII World Congress on Parkinson's Disease and Related Disorders - IAPRD November 12-15, 2017 in Ho Chi Minh City, Vietnam

 2017

European Society of Medical Oncology (ESMO)-Asia 2017 Travel Grant  to attend ESMO-ASIA 17–19 November 2017, Singapore

2017

International Movement Disorder Society (MDS), USA Travel grant to attend International Congress of Parkinson’s Disease and Movement Disorders, June 4-8, 2017 in Vancouver, BC, Canada

2017

1^st Asia Pacific HIV Clinical Forum Scholarship,  to attend Asia Pacific AIDS and Co-infections Conference (APACC) -2017, Hong Kong

2017

SEAL OF EXCELLENCE CERTIFICATE in collaboration with University of University of Gothenburg, Swedan by European Commission, Brussels, Belgium

2017

World Congress of Nephrology  (WCN) Travel Grant to attend ISN World Congress of Nephrology -2017, Mexico City, 21-25, 2017, Mexico

2017

TIC-PID Travel Grant, to attend TIC-PID Conference 17-19, March 2017, Taiwan

2016

European Society of Medical Oncology (ESMO)-Asia 2016 Travel Grant  to attend ESMO-ASIA  Singapore

2016

Top FIVE Most Cited Researcher (2014-2016), Saudi Pharmaceutical Journal, Scopus, Elsevier

2016

Best Research Paper Award-2015, Sam Higginbottom Institute of Agricultural Institute, Technology & Sciences, Allahabad, India

2016

Top THREE Most Cited Paper (2012-2016) Journal of Medical Myocology,  Scopus, Elsevier

2016

APACC Grant, 1^st Asian Pacific AIDS & Co-infection Conference, 17 – 19 May 2016, Hong Kong

2015-2017

Senior Visiting Fellowship, Chinese Scholarship Council (CSC), Shanghai Institute of Materia Medica, Shanghai, China (Not AVAILED)

2015

International Diabetes Federation Travel Grant, World Diabetes Congress 2015 Vancouver, , 30 Nov-4Dec, 2015 Canada

2015

Best Research Paper Award-2014, Sam Higginbottom Institute of Agricultural Institute, Technology & Sciences, Allahabad, India

2015

Early Career Chemist Award (American Chemical Society, USA), 2015 International Congress of Pacific Basin Societies, December 15-20, 2015, Honolulu, Hawaii, (Sponsored by: American Chemical Society, Canadian Society for Chemistry, Chemical Society of Japan, New Zealand Institute of Chemistry, Royal Australian Chemical Institute, Korean Chemical Society, Chinese Chemical Society) USA.

2015

ICPIC Innovation Academy Award, 3^rd International Conference on Prevention & Infection Control (ICPIC) to be held from 16 – 19 June 2015 in Geneva, Switzerland

2015

Selected to Attend TOP 15 participantsin International Malaria Workshop on the topic of Discovery of New Drugs Against Malaria at International Centre for Genetic Engineering and Biotechnology (ICGEB), 27 January – 6 February 2015, New Delhi, India

2014

HIV R4P Conference Full Scholarship to attend HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIV R4P), 28 – 31 October, 2014 in Cape Town, South Africa

2014

DST Young Scientist Travel Grant to visit 2nd Innovative Approaches for Identification of Antiviral Agents Summer School, Sardinia, Sept 28 – Oct 03 2014., Italy

2014

WCP2014 Congress Bursary to attend the 17th World Congress of Basic and Clinical Pharmacology in Cape Town, 13-18 July 2014, South Africa

2014

Young Investigator at 8^th European Cystic Fibrosis Young Investigator Meeting at Pasteur Institute, Paris, February 19th to 21st 2014. (First Non-European to be invited since the first meeting), France

2013

Invited Teacher to 79th Annual Meeting of Indian Academy of Sciences 8-10 November 2013

2013

World Society for Pediatric Infectious Diseases Symposium Fellowship(full funding) to attend World Society for Pediatric Infectious Diseases 2013 in Cape Town, November 19-22, 2013. South Africa

2013

Department of Science & Technology (DST), Government of India Travel award for visting 6th South African AIDS Conference, Durban, , 18-21 June 2013, vide letter no. SB/ITS-Y/01176/2013-2014, South Africa

2012

Top 25 Most Downloaded Articles, Journal de MycologieMédicale from the duration of April-September 2013, Elsevier, Netherlands.

2013

6th South African AIDS Conference Scholarship, 18-21 June 2013, Durban, South Africa

2012

European Union, Archimedes Foundation DoRa5 Scholarship to work with Prof Asko Uri, Leading Scientist, Chair for Bioorganic Chemistry, Institute of Chemistry, University of Tartu,; CSO, KINASERA Pharma, Estonia for a period of Sept 2012 – Feb 2013 on “Synthesis of ATP competitive Heterocyclic-Peptide Conjugate as Protein Kinase Inhibitor” (A part of PhD work, SIX MONTHS), Estonia

2012

Top three among the 25 Most Downloaded articles, Journal de MycologieMédicale from the duration of Jan-Dec 2012, , Elsevier, Netherlands

2012

Indian Academy of Sciences (IAS) – Indian National Science Academy (INSA) – National Academy of Science India (NASI) Summer Research Fellowship

2012

Marquis Who’s Who in the World 2012

2012

“Pneumococci and Pneumococcal Diseases International Symposium Fellowship” 8^th-International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-8) at 11-15^th March 2012, Foz du Igacau, Brazil.

2010

Best Poster Award in “II Louis Pasture Memorial National Symposium on Antimicrobial Resistance and Drug Discovery” at Dr. N.G.P. Arts and Science College, Coimbatore, India 2010

2006-08

“GATE Scholarship” from Ministry of Human Resources, Government of India during the tenure of M. Pharm

2002-06

“Kalayan Kosh Scholarship” from Government of Uttar Pradesh during the tenure of B. Pharm

Countries Visited